The Centers of Biomedical Research Excellence (COBRE) Program is offering this grant to support the renewal and strengthening of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions. This multi-phase program provides awards over three sequential five-year periods. This specific COBRE Phase 2 grant is for the purpose of further improving research infrastructure. It aims to strengthen successful Phase 1 centers by continuing to develop a critical mass of investigators with shared scientific interests. The goal is to enable these investigators to effectively compete for independent research funding and to further enhance the institution’s research capabilities.
Opportunity ID: 345025
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-23-063 |
| Funding Opportunity Title: | Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.859 — Biomedical Research and Research Training |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 20, 2022 |
| Last Updated Date: | Dec 20, 2022 |
| Original Closing Date for Applications: | May 28, 2025 |
| Current Closing Date for Applications: | May 28, 2025 |
| Archive Date: | Jul 03, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See full Funding Opportunity Announcement for additional details on eligibility |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The Centers of Biomedical Research Excellence (COBRE) program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions through awards for three sequential five-year phases. The purpose of the COBRE Phase 2 award is to strengthen successful COBRE Phase 1 centers established in Phase 1 through further improvements to research infrastructure and the continued development of a critical mass of investigators with shared scientific interests who are able to compete effectively for independent research funding and further improvements to research infrastructure at the institution. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-23-063.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 345025 Full Announcement-PAR-23-063 -> PAR-23-063-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00278982 | Apr 29, 2023 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289299 | Dec 02, 2024 | May 28, 2025 | View |
Package 1
Mandatory forms
345025 RR_SF424_5_0-5.0.pdf
345025 PHS398_CoverPageSupplement_5_0-5.0.pdf
345025 RR_OtherProjectInfo_1_4-1.4.pdf
345025 PerformanceSite_4_0-4.0.pdf
345025 RR_KeyPersonExpanded_4_0-4.0.pdf
345025 PHS398_ResearchPlan_5_0-5.0.pdf
345025 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
345025 PHS_Additional_IndirectCosts_2_0-2.0.pdf
345025 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
345025 RR_SF424_5_0-5.0.pdf
345025 PHS398_CoverPageSupplement_5_0-5.0.pdf
345025 RR_OtherProjectInfo_1_4-1.4.pdf
345025 PerformanceSite_4_0-4.0.pdf
345025 RR_KeyPersonExpanded_4_0-4.0.pdf
345025 PHS398_ResearchPlan_5_0-5.0.pdf
345025 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
345025 PHS_Additional_IndirectCosts_2_0-2.0.pdf
345025 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
